Literature DB >> 28138553

Influenza A induces dysfunctional immunity and death in MeCP2-overexpressing mice.

James C Cronk1,2,3,4, Jasmin Herz1,2, Taeg S Kim5,6, Antoine Louveau1,2, Emily K Moser5,7, Ashish K Sharma8, Igor Smirnov1,2, Kenneth S Tung6,9, Thomas J Braciale4,5,6,9, Jonathan Kipnis1,2,3,4.   

Abstract

Loss of function or overexpression of methyl-CpG-binding protein 2 (MeCP2) results in the severe neurodevelopmental disorders Rett syndrome and MeCP2 duplication syndrome, respectively. MeCP2 plays a critical role in neuronal function and the function of cells throughout the body. It has been previously demonstrated that MeCP2 regulates T cell function and macrophage response to multiple stimuli, and that immune-mediated rescue imparts significant benefit in Mecp2-null mice. Unlike Rett syndrome, MeCP2 duplication syndrome results in chronic, severe respiratory infections, which represent a significant cause of patient morbidity and mortality. Here, we demonstrate that MeCP2Tg3 mice, which overexpress MeCP2 at levels 3- to 5-fold higher than normal, are hypersensitive to influenza A/PR/8/34 infection. Prior to death, MeCP2Tg3 mice experienced a host of complications during infection, including neutrophilia, increased cytokine production, excessive corticosterone levels, defective adaptive immunity, and vascular pathology characterized by impaired perfusion and pulmonary hemorrhage. Importantly, we found that radioresistant cells are essential to infection-related death after bone marrow transplantation. In all, these results demonstrate that influenza A infection in MeCP2Tg3 mice results in pathology affecting both immune and nonhematopoietic cells, suggesting that failure to effectively respond and clear viral respiratory infection has a complex, multicompartment etiology in the context of MeCP2 overexpression.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28138553      PMCID: PMC5256138          DOI: 10.1172/jci.insight.88257

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  38 in total

1.  CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis.

Authors:  Geraldine Nouailles; Anca Dorhoi; Markus Koch; Jens Zerrahn; January Weiner; Kellen C Faé; Frida Arrey; Stefanie Kuhlmann; Silke Bandermann; Delia Loewe; Hans-Joachim Mollenkopf; Alexis Vogelzang; Catherine Meyer-Schwesinger; Hans-Willi Mittrücker; Gayle McEwen; Stefan H E Kaufmann
Journal:  J Clin Invest       Date:  2014-02-10       Impact factor: 14.808

2.  Pharmacological interference with the glucocorticoid system influences symptoms and lifespan in a mouse model of Rett syndrome.

Authors:  Sebastian Braun; Denise Kottwitz; Ulrike A Nuber
Journal:  Hum Mol Genet       Date:  2011-12-20       Impact factor: 6.150

3.  Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.

Authors:  Izumi Maezawa; Lee-Way Jin
Journal:  J Neurosci       Date:  2010-04-14       Impact factor: 6.167

4.  Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28.

Authors:  Michael J Friez; Julie R Jones; Katie Clarkson; Herbert Lubs; Dianne Abuelo; Jo-Ann Blaymore Bier; Shashidhar Pai; Richard Simensen; Charles Williams; Philip F Giampietro; Charles E Schwartz; Roger E Stevenson
Journal:  Pediatrics       Date:  2006-11-06       Impact factor: 7.124

5.  Functional characterization of the MECP2/IRAK1 lupus risk haplotype in human T cells and a human MECP2 transgenic mouse.

Authors:  Kristi A Koelsch; Ryan Webb; Matlock Jeffries; Mikhail G Dozmorov; Mark Barton Frank; Joel M Guthridge; Judith A James; Jonathan D Wren; Amr H Sawalha
Journal:  J Autoimmun       Date:  2013-02-18       Impact factor: 7.094

6.  Mild overexpression of MeCP2 causes a progressive neurological disorder in mice.

Authors:  Ann L Collins; Jonathan M Levenson; Alexander P Vilaythong; Ronald Richman; Dawna L Armstrong; Jeffrey L Noebels; J David Sweatt; Huda Y Zoghbi
Journal:  Hum Mol Genet       Date:  2004-09-06       Impact factor: 6.150

7.  MeCP2 deficiency enhances glutamate release through NF-κB signaling in myeloid derived cells.

Authors:  Cliona M O'Driscoll; Walter E Kaufmann; Joseph P Bressler
Journal:  J Neuroimmunol       Date:  2013-09-12       Impact factor: 3.478

8.  Inflammatory lung disease in Rett syndrome.

Authors:  Claudio De Felice; Marcello Rossi; Silvia Leoncini; Glauco Chisci; Cinzia Signorini; Giuseppina Lonetti; Laura Vannuccini; Donatella Spina; Alessandro Ginori; Ingrid Iacona; Alessio Cortelazzo; Alessandra Pecorelli; Giuseppe Valacchi; Lucia Ciccoli; Tommaso Pizzorusso; Joussef Hayek
Journal:  Mediators Inflamm       Date:  2014-03-17       Impact factor: 4.711

9.  MeCP2, a key contributor to neurological disease, activates and represses transcription.

Authors:  Maria Chahrour; Sung Yun Jung; Chad Shaw; Xiaobo Zhou; Stephen T C Wong; Jun Qin; Huda Y Zoghbi
Journal:  Science       Date:  2008-05-30       Impact factor: 47.728

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  3 in total

1.  The Pathophysiology of Rett Syndrome With a Focus on Breathing Dysfunctions.

Authors:  Jan-Marino Ramirez; Marlusa Karlen-Amarante; Jia-Der Ju Wang; Nicholas E Bush; Michael S Carroll; Debra E Weese-Mayer; Alyssa Huff
Journal:  Physiology (Bethesda)       Date:  2020-11-01

Review 2.  Rett syndrome from bench to bedside: recent advances.

Authors:  Yann Ehinger; Valerie Matagne; Laurent Villard; Jean-Christophe Roux
Journal:  F1000Res       Date:  2018-03-26

Review 3.  Sex Dimorphism in Pulmonary Hypertension: The Role of the Sex Chromosomes.

Authors:  Daria S Kostyunina; Paul McLoughlin
Journal:  Antioxidants (Basel)       Date:  2021-05-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.